Authors will be asked to assign a theme to their abstract in the abstract submission portal. This can be selected from the following:

1. Epidemiology and Informatics (EPI)
2. Genetics and genomics (GEN)
3. In vitro experimental models (IVT)
4. In vivo experimental models (IVV)
5. Human cell biology and pathology (HCB)
6. Tissue biomarkers (BIO)
7. Pre-clinical therapeutic strategies (TST)
8. Clinical imaging and electrophysiology (IMG)
9. Clinical trials and trial design (CLT)
10. Disease stratification and phenotyping of patients (DSP)
11. Cognitive and psychological assessment and support (COG)
12. Clinical management and support (CMS)

Please click the orange button above to be taken to the abstract submission portal. For full guidelines and step-by-step instructions, please see the Conditions of Acceptance and Instructions.

Submissions are limited to two abstracts per presenting author.

No, authors no longer need to register before submitting an abstract. Presenting authors will be required to pay the appropriate in-person registration fee by 8 September 2023. Formal acceptance of an abstract is conditional upon payment of the full registration fee. Refunds will be available in the event of an abstract being rejected.

Abstracts will be published in an online open access supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. This abstract book will be published online on the Taylor and Francis website and can be found via the Symposium website (symposium.mndassociation.org), in November 2023. Abstracts accepted as ‘WIP/CP’ will be published on the MND Association’s Symposium website.

By submitting an abstract, you consent to give us the license to act on your behalf with the Taylor & Francis group to publish your abstract in the symposium supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

WIP/CP stands for work in progress/care practice. WIP/CP is defined as: preliminary work (little or no data/results), care practice or case studies.

Yes, abstracts may be submitted even if previously presented at a national/international meeting.

Once the submission deadline has passed, abstracts will be reviewed by the Symposium Programme Committee. We will inform you of the decision in late August and if you have been accepted.  This will be followed by a second notification in September/October which will include specific presentation theme/session, time and date information. Poster presenters will also receive details and instructions on poster guidelines and how to submit their poster material (poster PDF) to our virtual platform for our virtual delegates  before the upload deadline (15 November 2023, 23:59 UK time).